News
The FDA misses its deadline again to propose a ban on formaldehyde in hair products
A hairdresser straightens a woman’s hair by applying a hair product. A delayed proposal by the Food and Drug Administration would ban the use of formaldehyde as an ingredient in hair relaxers and hair straighteners.
Getty Images
hide caption
toggle caption
Getty Images
The Food and Drug Administration’s proposal to ban the use of formaldehyde as an ingredient in hair relaxers and hair straighteners on the market in the U.S. has been pushed back yet again. The deadline for the agency’s proposal, at this time, still remains unclear.
The FDA’s proposed rule takes a large step in shedding light on the potential harm that formaldehyde — a highly toxic, colorless gas — can cause to the many Black women and other women of color who typically use straightening products.
In October, NPR reported that the federal agency proposed the ban and scheduled its implementation for April 2024. The first deadline for the scheduled ban implementation was missed and pushed back to July 2024. Most recently, the agency moved the target date to September 2024.
On April 3, the FDA told NPR in an email that the action date for the proposed ban was set for April 2024 and that officials were “still developing the proposed rule.”
At that time, a spokesperson declined to comment further about the timing or the ban’s detailed content.
But when pressed about the status of the ban to the federal agency in May and, most recently, this month, an FDA spokesperson told NPR that the proposed rule “continues to be a high priority.” They declined again to comment further about its timing or content.
When asked Friday for clarification about why there have been numerous delays in implementing the proposed ban, a spokesperson told NPR that the process for implementing proposed rules “takes time.”
“Before a proposed rule can be published in the Federal Register for public comment, it must be reviewed and approved within FDA and other parts of the Federal government,” the FDA spokesperson said in a statement.
Allison Stevenson, an attorney who represents product manufacturers and retailers, says that while we should expect to see a ban on formaldehyde, it’s no surprise that the FDA has delayed the proposed ban several times.
“There are a lot of moving parts … this all falls under legislation that is still relatively new, in almost all respects. And so it’s not uncommon to see things get delayed for one reason or the other,” she said.
Stevenson predicts that the ban will likely not occur until 2025. She says the proposed ban is necessary to protect the health and safety of communities of color.
“The regulation is necessary to protect the health and safety of communities of color, Stevenson said. “I certainly don’t believe that the delay should be indicative to anyone that the FDA is not making this issue a priority,” she added.
What are the health risks associated with formaldehyde?
Formaldehyde is a toxic, colorless and strong-smelling gas that presents health hazards when breathed into the lungs or when it comes into contact with the eyes or skin, according to the FDA.
In 2022, researchers at the National Institutes of Health released a study that showed an increased risk of hormone-related cancer in women who have used the chemicals in their hair. The findings in the report were especially concerning for Black women, who are far more likely to report using such products, including many kinds of chemical relaxers, Brazilian blowouts and keratin treatments.
“We estimated that 1.64% of women who never used hair straighteners would go on to develop uterine cancer by the age of 70; but for frequent users, that risk goes up to 4.05%,” lead author Alexandra White, the head of the National Institute of Environmental Health Sciences Environment and Cancer Epidemiology group, told NPR in 2022.
Once the gas is present in the air at levels exceeding 0.1 parts per million, those in contact with it can experience harmful side effects such as watery eyes, burning in the eyes, nose, and throat, coughing, wheezing, nausea, and skin irritation. (Essentially, the more exposure one has to products containing formaldehyde — in terms of time and concentration — the higher the health risk.)
The long-term effects associated with the use of formaldehyde
The use of formaldehyde can have several long-term effects associated with it, which can include an increased number of headaches, asthma, contact dermatitis and possibly cancer.
Hair relaxers and hair straightening products have also been linked to risks associated with uterine cancer, breast cancer and even ovarian cancer — especially for Black women.
According to the New York State Department of Health, more than 150 hair-straightening products on store shelves contain formaldehyde. Investigators discovered that products that claimed to be “formaldehyde-free,” “organic,” or even “natural” actually contained the highly toxic chemical when tested.
Aside from hair straighteners and smoothers, formaldehyde is used in glues, resins, dyes, textiles, disinfectants, building materials, automobile parts, embalming, and laboratories, according to the Centers for Disease Control and Prevention.
One observer of the current Senate race in Louisiana noted that Sen. Bill Cassidy could lose his reelection bid.
Annie Flanagan for NPR
hide caption
toggle caption
Annie Flanagan for NPR
Sen. Bill Cassidy lost Saturday’s Louisiana Republican primary according to a race call by the Associated Press.
Cassidy, who served two terms in the Senate, was one of seven Republican senators who voted to convict President Trump after the January 6th insurrection at the Capitol. That vote put him at odds with Trump and his MAGA coalition, ultimately leading Trump to push Rep. Julia Letlow to run against Cassidy.
Cassidy’s bid for a third term was viewed as a test of Trump’s grip on the party–and of what voters want from their representatives in Washington. The primary pitted Cassidy, a veteran lawmaker, former physician and chair of the powerful Senate health committee, against Letlow, a political newcomer and a millennial MAGA loyalist.
A detailed view of a hat that reads, Run Julia Run, is seen at a campaign event for Rep. Julia Letlow (R-LA) on May 6, 2026 in Franklinton, Louisiana.
Tyler Kaufman/Getty Images
hide caption
toggle caption
Tyler Kaufman/Getty Images
A former college administrator, Letlow won a special election in 2021 for the House seat her late husband, Luke, was set to assume before he died from COVID in 2020.
In Congress, Letlow sponsored a bill to collect oral histories from the pandemic and has focused on education and children. She introduced the “Parents Bill of Rights Act,” which would allow parents to review classroom materials like library books and require schools to notify parents if their child requests different pronouns, locker rooms or sports teams.
She also serves on the powerful appropriations committee and has embraced Trump’s agenda.
Letlow, who came first in Saturday’s primary, will face Louisiana state Treasurer John Fleming in the runoff on June 27. Cassidy came in third.
The election result is a victory for President Trump who has put Republican loyalty to the test on the ballot so far this year in Indiana state senate primaries and in Cassidy’s race.
Another major test of Trump’s influence comes in Kentucky’s primary on Tuesday when Republican Rep. Thomas Massie, who has found himself at odds with the president, faces a challenger endorsed by Trump.
News
Brass bands in Beijing make way for sticker shock at home as Trump returns to escalating inflation
WASHINGTON (AP) — President Donald Trump returned from the spectacle of a Chinese state visit to a less than welcoming U.S. economy — with the military band and garden tour in Beijing giving way to pressure over how to fix America’s escalating inflation rate.
Consumer inflation in the United States increased to 3.8% annually in April, higher than what he inherited as the Iran war and the Republican president’s own tariffs have pushed up prices. Inflation is now outpacing wage gains and effectively making workers poorer. The Cleveland Federal Reserve estimates that annual inflation could reach 4.2% in May as the war has kept oil and gasoline prices high.
Trump’s time with Chinese leader Xi Jinping appears unlikely to help the U.S. economy much, despite Trump’s claims of coming trade deals. The trip occurred as many people are voting in primaries leading into the November general election while having to absorb the rising costs of gasoline, groceries, utility bills, jewelry, women’s clothing, airplane tickets and delivery services. Democrats see the moment as a political opportunity.
“He’s returning to a dumpster fire,” said Lindsay Owens, executive director of Groundwork Collaborative, a liberal think tank focused on economic issues. “The president will not have the faith and confidence of the American people — the economy is their top issue and the president is saying, ‘You’re on your own.’”
The president’s trip to Beijing and his recent comments that indicated a tone-deafness to voters’ concerns about rising prices have suggested his focus is not on the American public and have undermined Republicans who had intended to campaign on last year’s tax cuts as helping families.
Trump described the trip as a victory, saying on social media that Xi “congratulated me on so many tremendous successes,” as the U.S. president has praised their relationship.
Trump told reporters that Boeing would be selling 200 aircraft — and maybe even 750 “if they do a good job” — to the Chinese. He said American farmers would be “very happy” because China would be “buying billions of dollars of soybeans.”
“We had an amazing time,” Trump said as he flew home on Air Force One, and told Fox News’ Bret Baier in an interview that gasoline prices were just some “short-term pain” and would “drop like a rock” once the war ends.
Inflationary pain is not a factor in how Trump handles Iran
Trump departed from the White House for China by saying the negotiations over the Iran war depended on stopping Tehran from developing nuclear weapons. “I don’t think about Americans’ financial situation. I don’t think about anybody. I think about one thing: We cannot let Iran have a nuclear weapon,” Trump said.
That remark prompted blowback because it suggested to some that Trump cared more about challenging Iran than fighting inflation at home. Trump defended his words, telling Fox News: “That’s a perfect statement. I’d make it again.”
The White House has since stressed that Trump is focused on inflation.
Asked later about the president’s words, Vice President JD Vance said there had been a “misrepresentation” of the remarks. White House spokesman Kush Desai said the “administration remains laser-focused on delivering growth and affordability on the homefront” while indicating actions would be taken on grocery prices.
But as Trump appeared alongside Xi, new reports back home showed inflation rising for businesses and interest rates climbing on U.S. government debt.
His comments that Boeing would sell 200 jets to China caused the company’s stock price to fall because investors had expected a larger number. There was little concrete information offered about any trade agreements reached during the summit, including Chinese purchases of U.S. exports such as liquefied natural gas and beef.
“Foreign policy wins can matter politically, but only if voters feel stability and affordability in their daily lives,” said Brittany Martinez, a former Republican congressional aide who is the executive director of Principles First, a center-right advocacy group focused on democracy issues.
“Midterms are almost always a referendum on cost of living and public frustration, and Republicans are not immune from the same inflation and affordability pressures that hurt Democrats in recent cycles,” she added.
Democrats see Trump as vulnerable
Democratic lawmakers are seizing on Trump’s comments before his trip as proof of his indifference to lowering costs. There is potential staying power of his remarks as Americans head into Memorial Day weekend facing rising prices for the hamburgers and hot dogs to be grilled.
“What Americans do not see is any sympathy, any support, or any plan from Trump and congressional Republicans to lower costs – in fact, they see the opposite,” Senate Democratic leader Chuck Schumer of New York said Thursday.
Vance faulted the Biden administration for the inflation problem even though the inflation rate is now higher than it was when Trump returned to the White House in January 2025 with a specific mandate to fix it.
“The inflation number last month was not great,” Vance said Wednesday, but he then stressed, “We’re not seeing anything like what we saw under the Biden administration.”
Inflation peaked at 9.1% in June 2022 under Biden, a Democrat. By the time Trump took the oath of office, it was a far more modest 3%.
Trump’s inflation challenge could get harder
The data tells a different story as higher inflation is spreading into the cost of servicing the national debt.
Over the past week, the interest rate charged on 10-year U.S. government debt jumped from 4.36% to 4.6%, an increase that implies higher costs for auto loans and mortgages.
“My fear is that the layers of supply shocks that are affecting the U.S. economy will only further feed into inflationary pressures,” said Gregory Daco, chief economist at EY-Parthenon.
Daco noted that last year’s tariff increases were now translating into higher clothing prices. With the Supreme Court ruling against Trump’s ability to impose tariffs by declaring an economic emergency, his administration is preparing a new set of import taxes for this summer.
Daco stressed that there have been a series of supply shocks. First, tariffs cut into the supply of imports. In addition, Trump’s immigration crackdown cut into the supply of foreign-born workers. Now, the effective closure of the Strait of Hormuz has cut off the vital waterway used to ship 20% of global oil supplies.
“We’re seeing an erosion of growth,” Daco said.
Dr. Tracy Beth Hoeg, the Food and Drug Administration’s top drug regulator, said she was fired from the agency Friday after she declined to resign.
She said she did not know who had ordered her firing or why, nor whether Health Secretary Robert F. Kennedy Jr. knew of her fate. The Department of Health and Human Services did not immediately respond to a request for comment.
The departure reflected the upheaval at the F.D.A., days after the resignation of Dr. Marty Makary, the agency commissioner. Dr. Makary had become a lightning rod for critics of the agency’s decisions to reject applications for rare disease drugs and to delay a report meant to supply damaging evidence about the abortion drug mifepristone. He also spent months before his departure pushing back on the White House’s requests for him to approve more flavored vapes, the reason he ultimately cited for leaving.
Dr. Hoeg’s hiring had startled public health leaders who were familiar with her track record as a vaccine skeptic, and she played a leading role in some of the agency’s most divisive efforts during her tenure. She worked on a report that purportedly linked the deaths of children and young adults to Covid vaccines, a dossier the agency has not released publicly. She was also the co-author of a document describing Mr. Kennedy’s decision to pare the recommendations for 17 childhood vaccines down to 11.
But in an interview on Friday, Dr. Hoeg said she “stuck with the science.”
“I am incredibly proud of the work we were doing,” Dr. Hoeg said, adding, “I’m glad that we didn’t give in to any pressures to approve drugs when it wasn’t appropriate.”
As the director of the agency’s Center for Drug Evaluation and Research, she was a political appointee in a role that had been previously occupied by career officials. An epidemiologist who was trained in the United States and Denmark, she worked on efforts to analyze drug safety and on a panel to discuss the use of serotonin reuptake inhibitors, the most widely prescribed class of antidepressants, during pregnancy. She also worked on efforts to reduce animal testing and was the agency’s liaison to an influential vaccine committee.
She made sure that her teams approved drugs only when the risk-benefit balance was favorable, she said.
The firing worsens the leadership vacuum at the F.D.A. and other agencies, with temporary leaders filling the role of commissioner, food chief and the head of the biologics center, which oversees vaccines and gene therapies. The roles of surgeon general and director of the Centers for Disease Control and Prevention are also unfilled.
-
North Dakota2 minutes agoHope man dies after truck strikes parked dozer in Steele County
-
Ohio8 minutes agoMaybe Ohio State AD Ross Bjork should sit in regular-guy seats, wait in line, etc.
-
Oklahoma14 minutes ago2 teens arrested after back-to-back shootings near Paycom Center
-
Oregon20 minutes agoThis Is The Friendliest Small Town in Oregon
-
Pennsylvania26 minutes agoThe new political era of insurgent candidates is roiling the Pennsylvania primary
-
Rhode Island32 minutes agoMy doctor knew what care I needed. My insurance denied it | Opinion
-
South-Carolina38 minutes agoSouth Carolina Lottery Powerball, Pick 3 results for May 16, 2026
-
South Dakota44 minutes agoSouth Dakota softball’s run ends in extra-inning loss to Grand Canyon
